These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cancer immunotherapy via nucleic acid aptamers. Khedri M; Rafatpanah H; Abnous K; Ramezani P; Ramezani M Int Immunopharmacol; 2015 Dec; 29(2):926-936. PubMed ID: 26603636 [TBL] [Abstract][Full Text] [Related]
25. Application of Aptamers in Virus Detection and Antiviral Therapy. Zou X; Wu J; Gu J; Shen L; Mao L Front Microbiol; 2019; 10():1462. PubMed ID: 31333603 [TBL] [Abstract][Full Text] [Related]
26. Novel insights into the role of aptamers in the fight against cancer. Maimaitiyiming Y; Hong F; Yang C; Naranmandura H J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295 [TBL] [Abstract][Full Text] [Related]
27. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine. Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890 [TBL] [Abstract][Full Text] [Related]
28. Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. Fu Z; Xiang J Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316469 [TBL] [Abstract][Full Text] [Related]
29. Aptamer Therapeutics in Cancer: Current and Future. Morita Y; Leslie M; Kameyama H; Volk DE; Tanaka T Cancers (Basel); 2018 Mar; 10(3):. PubMed ID: 29562664 [TBL] [Abstract][Full Text] [Related]
30. Generation of Specific Aptamers. Liu S; Suzuki Y; Inui M Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458 [TBL] [Abstract][Full Text] [Related]
31. [Aptamers in clinical diagnostics]. SzpechciĆski A; Grzanka A Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061 [TBL] [Abstract][Full Text] [Related]
32. Advances in Oligonucleotide Aptamers for NSCLC Targeting. Rotoli D; Santana-Viera L; Ibba ML; Esposito CL; Catuogno S Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842557 [TBL] [Abstract][Full Text] [Related]
33. Application of aptamers for targeted therapeutics. Ray P; Viles KD; Soule EE; Woodruff RS Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807 [TBL] [Abstract][Full Text] [Related]
34. Aptamers against extracellular targets for in vivo applications. Pestourie C; Tavitian B; Duconge F Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620 [TBL] [Abstract][Full Text] [Related]
35. [Aptamers in the Treatment of Bacterial Infections: Problems and Prospects]. Zeninskaya NA; Kolesnikov AV; Ryabko AK; Shemyakin IG; Dyatlov IA; Kozyr AV Vestn Ross Akad Med Nauk; 2016; 71(5):350-8. PubMed ID: 29297663 [TBL] [Abstract][Full Text] [Related]
36. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics. Zhong Y; Zhao J; Li J; Liao X; Chen F Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127 [TBL] [Abstract][Full Text] [Related]
37. Absolute quantification of cell-bound DNA aptamers during SELEX. Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949 [TBL] [Abstract][Full Text] [Related]
38. Aptamers: potential applications to pancreatic cancer therapy. Rialon KL; White RR Anticancer Agents Med Chem; 2011 Jun; 11(5):434-41. PubMed ID: 21492073 [TBL] [Abstract][Full Text] [Related]
39. Nucleic acid aptamers in human viral disease. Zhang Z; Blank M; Schluesener HJ Arch Immunol Ther Exp (Warsz); 2004; 52(5):307-15. PubMed ID: 15507871 [TBL] [Abstract][Full Text] [Related]
40. Recent advances in aptamer-based therapeutic strategies for targeting cancer stem cells. Liu B; Liu J; Hu X; Xiang W; Hou W; Li C; Wang J; Yao K; Tang J; Long Z; Wang L; Liu J Mater Today Bio; 2023 Apr; 19():100605. PubMed ID: 36969696 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]